Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 1.000 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.610 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.564 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.555 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.549 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.534 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.530 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.527 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.527 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.527 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.520 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.519 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.519 | |
| 3dko | IHZ | Ephrin type-A receptor 7 | 2.7.10.1 | 0.514 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.513 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.513 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.512 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.510 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.510 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.509 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.508 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.507 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.507 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.506 | |
| 3p9t | TCL | Repressor | / | 0.505 | |
| 5g53 | NEC | Adenosine receptor A2a | / | 0.505 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.503 | |
| 4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.502 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.502 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.501 | |
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.498 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.498 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.498 | |
| 3uvv | REA | Retinoic acid receptor RXR-alpha | / | 0.496 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.496 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.495 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.495 | |
| 3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.495 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.494 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.493 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.493 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.493 | |
| 4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.493 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.492 | |
| 4j52 | 1J3 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.492 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.490 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.489 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.488 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.488 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.488 | |
| 3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.487 | |
| 3njo | PYV | Abscisic acid receptor PYR1 | / | 0.487 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.487 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.486 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.485 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.484 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.484 | |
| 3tda | PN0 | Cytochrome P450 2D6 | / | 0.484 | |
| 3vg9 | ZMA | Adenosine receptor A2a | / | 0.483 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.482 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.482 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.482 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.481 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.481 | |
| 2ydo | ADN | Adenosine receptor A2a | / | 0.481 | |
| 2p1u | 4TN | Retinoic acid receptor RXR-alpha | / | 0.480 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.480 | |
| 1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.479 | |
| 3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.479 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.479 | |
| 1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.478 | |
| 2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.478 | |
| 3d74 | NBB | Pheromone-binding protein ASP1 | / | 0.478 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.478 | |
| 4uxq | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.478 | |
| 2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.477 | |
| 3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.477 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.477 | |
| 2xk4 | OL2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.476 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.476 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.476 | |
| 5ckw | ANP | Uncharacterized protein | / | 0.476 | |
| 2rab | NAD | Glutathione amide reductase | / | 0.474 | |
| 4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.474 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 2xk8 | 5R1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.473 | |
| 4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.473 | |
| 1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.472 | |
| 2zb8 | IMN | Prostaglandin reductase 2 | 1.3.1.48 | 0.472 | |
| 3c1x | CKK | Hepatocyte growth factor receptor | 2.7.10.1 | 0.472 | |
| 3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.472 | |
| 3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.472 | |
| 4k4j | 1O8 | Retinoic acid receptor RXR-alpha | / | 0.472 | |
| 1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.471 | |
| 3d78 | NBB | Pheromone-binding protein ASP1 | / | 0.471 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.471 | |
| 2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.470 | |
| 3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.470 | |
| 4gi2 | NAP | Crotonyl-CoA carboxylase/reductase | / | 0.470 | |
| 4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.470 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.470 | |
| 2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.469 | |
| 2ydv | NEC | Adenosine receptor A2a | / | 0.469 | |
| 3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.469 | |
| 3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.469 | |
| 3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.469 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.469 | |
| 4kln | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.469 | |
| 4m8e | 29V | Retinoic acid receptor RXR-alpha | / | 0.469 | |
| 4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.469 | |
| 1l2j | ETC | Estrogen receptor beta | / | 0.468 | |
| 1y6b | AAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.468 | |
| 3oap | REA | Retinoic acid receptor RXR-alpha | / | 0.468 | |
| 3u8h | BHP | Phospholipase A2, membrane associated | / | 0.468 | |
| 2xkc | 4VQ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.467 | |
| 3jwm | 5WB | Dihydrofolate reductase | / | 0.467 | |
| 3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.467 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.467 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.467 | |
| 1uhl | MEI | Retinoic acid receptor RXR-beta | / | 0.466 | |
| 2cl5 | BIE | Catechol O-methyltransferase | 2.1.1.6 | 0.466 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.466 | |
| 3eel | 53T | Uncharacterized protein | / | 0.466 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.466 | |
| 4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.466 | |
| 1fby | REA | Retinoic acid receptor RXR-alpha | / | 0.465 | |
| 1u0h | ONM | Adenylate cyclase type 2 | / | 0.465 | |
| 1u0h | ONM | Adenylate cyclase type 5 | / | 0.465 | |
| 2dqs | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.465 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.465 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.465 | |
| 4gh3 | 0EV | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.465 | |
| 1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.464 | |
| 1o6r | R19 | Squalene--hopene cyclase | 4.2.1.129 | 0.464 | |
| 1rd4 | L08 | Integrin alpha-L | / | 0.464 | |
| 1xds | DRA | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.464 | |
| 2dw4 | FAD | Lysine-specific histone demethylase 1A | 1 | 0.464 | |
| 4d7e | FAD | Putative lysine-N-oxygenase | / | 0.464 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.464 | |
| 4xoq | F42 | Coenzyme F420:L-glutamate ligase | / | 0.464 | |
| 2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.463 | |
| 2gvc | FAD | Thiol-specific monooxygenase | 1.14.13 | 0.463 | |
| 4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.463 | |
| 4iah | 1DX | Alr2278 protein | / | 0.463 | |
| 4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
| 1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.462 | |
| 1xls | REA | Retinoic acid receptor RXR-alpha | / | 0.462 | |
| 2e99 | B08 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.462 | |
| 2j0v | GDP | Rac-like GTP-binding protein ARAC7 | / | 0.462 | |
| 3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.462 | |
| 3htj | ET | EbrA repressor | / | 0.462 | |
| 4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.462 | |
| 4u9z | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.462 | |
| 1kqw | RTL | Cellular retinol-binding protein type II | / | 0.461 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.461 | |
| 3ar7 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.461 | |
| 3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.461 | |
| 3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.461 | |
| 3oq1 | 3OQ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.461 | |
| 4dsc | A8S | Abscisic acid receptor PYL3 | / | 0.461 | |
| 4jqh | 1MF | Alr2278 protein | / | 0.461 | |
| 1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.460 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.460 | |
| 3jw5 | TOP | Dihydrofolate reductase | / | 0.460 | |
| 3jwc | EKB | Dihydrofolate reductase | / | 0.460 | |
| 4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.460 | |
| 4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.460 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.460 | |
| 4qx5 | CMP | cGMP-dependent protein kinase 1 | 2.7.11.12 | 0.460 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.460 | |
| 1ro6 | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.459 | |
| 1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.459 | |
| 3up3 | XCA | aceDAF-12 | / | 0.459 | |
| 4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.459 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.459 | |
| 1diu | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
| 1rgs | CMP | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.458 | |
| 2a4n | COA | Aac(6')-Ii protein | / | 0.458 | |
| 2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.458 | |
| 3d75 | NBB | Pheromone-binding protein ASP1 | / | 0.458 | |
| 3fy9 | XCF | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
| 3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
| 3nal | DBK | Calcium-transporting ATPase | / | 0.458 | |
| 3qlx | QLR | Uncharacterized protein | / | 0.458 | |
| 3v94 | WYQ | Phosphodiesterase | / | 0.458 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.458 | |
| 4f1m | ACP | Probable serine/threonine-protein kinase roco4 | 2.7.11.1 | 0.458 | |
| 4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
| 4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
| 4m8h | R4M | Retinoic acid receptor RXR-alpha | / | 0.458 | |
| 1jxz | BCA | 4-chlorobenzoyl coenzyme A dehalogenase | 3.8.1.7 | 0.457 | |
| 1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.457 | |
| 3aba | FLI | Cytochrome P450 | / | 0.457 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.457 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.457 | |
| 1og5 | SWF | Cytochrome P450 2C9 | / | 0.456 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.456 | |
| 2p1t | 3TN | Retinoic acid receptor RXR-alpha | / | 0.456 | |
| 2wqo | VGK | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.456 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.456 | |
| 3sgt | P09 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | / | 0.456 | |
| 3sgv | 2BJ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.456 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.456 | |
| 5ab7 | MLC | Nonspecific lipid-transfer protein, putative | / | 0.456 | |
| 5dp2 | NAP | CurF | / | 0.456 | |
| 4ug2 | NGI | Adenosine receptor A2a | / | 0.456 | |
| 1lco | PPY | Cytochrome b2, mitochondrial | 1.1.2.3 | 0.455 | |
| 1rdt | L79 | Retinoic acid receptor RXR-alpha | / | 0.455 | |
| 3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.455 | |
| 4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.455 | |
| 4htx | 19F | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.455 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.455 | |
| 4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
| 5doz | NDP | JamJ | / | 0.455 | |
| 1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.454 | |
| 2j9l | ATP | H(+)/Cl(-) exchange transporter 5 | / | 0.454 | |
| 2ntj | P1H | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
| 2osc | MUH | Angiopoietin-1 receptor | 2.7.10.1 | 0.454 | |
| 2yac | 937 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.454 | |
| 3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.454 | |
| 3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.454 | |
| 3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 4ea1 | 3RX | Dehydrosqualene synthase | / | 0.454 | |
| 4few | PP2 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.454 | |
| 4fgh | 0U6 | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.454 | |
| 4iae | 1DX | Alr2278 protein | / | 0.454 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.453 | |
| 1e79 | ADP | ATP synthase subunit alpha, mitochondrial | / | 0.453 | |
| 1e79 | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.453 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.453 | |
| 2h42 | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.453 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.453 | |
| 2rjp | 886 | A disintegrin and metalloproteinase with thrombospondin motifs 4 | 3.4.24.82 | 0.453 | |
| 3k47 | D09 | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
| 3sgy | 06W | Dihydrofolate reductase | 1.5.1.3 | 0.453 | |
| 4ajw | VWN | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 2.7.1.153 | 0.453 | |
| 1cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
| 1g63 | FMN | Epidermin decarboxylase | 4.1.1 | 0.452 | |
| 1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.452 | |
| 2zru | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.452 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.452 | |
| 3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.452 | |
| 3q2m | CKI | Spectinomycin phosphotransferase | / | 0.452 | |
| 3w0h | W12 | Vitamin D3 receptor | / | 0.452 | |
| 4bgi | I4I | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
| 4r21 | STR | Cytochrome P450 family 17 polypeptide 2 | / | 0.452 | |
| 1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.451 | |
| 1tsd | F89 | Thymidylate synthase | / | 0.451 | |
| 1upw | 444 | Oxysterols receptor LXR-beta | / | 0.451 | |
| 2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.451 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.451 | |
| 3p2o | NAD | Bifunctional protein FolD | / | 0.451 | |
| 4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.451 | |
| 4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.451 | |
| 4rup | H97 | Vitamin D3 receptor A | / | 0.451 | |
| 1dis | BDM | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
| 1e6e | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.450 | |
| 1k74 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.450 | |
| 1yho | TRR | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
| 2agv | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.450 | |
| 2vd0 | D27 | Hematopoietic prostaglandin D synthase | / | 0.450 | |
| 3da2 | 4MD | Carbonic anhydrase 13 | 4.2.1.1 | 0.450 | |
| 3iro | 2CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.450 | |
| 3n0y | APC | Adenylate cyclase 2 | / | 0.450 | |
| 3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
| 4rbs | 0RV | Metallo-beta-lactamase type 2 | / | 0.450 | |
| 5kf2 | COA | Predicted acetyltransferase | / | 0.450 | |
| 1kzj | CB3 | Thymidylate synthase | / | 0.449 | |
| 1yc2 | NAD | NAD-dependent protein deacylase 2 | / | 0.449 | |
| 2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.449 | |
| 2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.449 | |
| 2p1v | 5TN | Retinoic acid receptor RXR-alpha | / | 0.449 | |
| 2pnj | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.449 | |
| 2pun | ACP | Methylthioribose kinase | 2.7.1.100 | 0.449 | |
| 2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.449 | |
| 2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.449 | |
| 3gie | ACP | Sensor histidine kinase DesK | 2.7.13.3 | 0.449 | |
| 3is9 | AC7 | Gag-Pol polyprotein | 2.7.7.49 | 0.449 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.449 | |
| 3nxr | D2D | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.449 | |
| 3vrw | YS5 | Vitamin D3 receptor | / | 0.449 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.449 | |
| 2b01 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.448 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
| 2xnm | WGZ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.448 | |
| 2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.448 | |
| 4ap1 | NAP | Steroid monooxygenase | / | 0.448 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.448 | |
| 4iw8 | KN3 | Estrogen receptor | / | 0.448 | |
| 1nzy | BCA | 4-chlorobenzoyl coenzyme A dehalogenase | 3.8.1.7 | 0.447 | |
| 1qkn | RAL | Estrogen receptor beta | / | 0.447 | |
| 2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.447 | |
| 2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
| 2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.447 | |
| 3cse | N22 | Uncharacterized protein | / | 0.447 | |
| 3hl0 | NAD | Maleylacetate reductase | / | 0.447 | |
| 3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.447 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.447 | |
| 3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
| 3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.447 | |
| 3tfn | 2CJ | Dehydrosqualene synthase | / | 0.447 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.447 | |
| 4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.447 | |
| 4dm6 | TTB | Retinoic acid receptor beta | / | 0.447 | |
| 4elf | 35I | Dihydrofolate reductase | / | 0.447 | |
| 4gqk | ADP | Actin cross-linking toxin VgrG1 | / | 0.447 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 4i8v | BHF | Cytochrome P450 1A1 | 1.14.14.1 | 0.447 | |
| 4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.447 | |
| 1dkf | BMS | Retinoic acid receptor alpha | / | 0.446 | |
| 1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.446 | |
| 1vj3 | TAB | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
| 2e98 | B29 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.446 | |
| 2has | C3O | Vitamin D3 receptor | / | 0.446 | |
| 2qjp | SMA | Cytochrome b | / | 0.446 | |
| 2wes | FAD | Tryptophan 5-halogenase | / | 0.446 | |
| 2xtb | KRM | Adenosine kinase, putative | / | 0.446 | |
| 2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
| 3ar6 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.446 | |
| 3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
| 3eej | 53R | Uncharacterized protein | / | 0.446 | |
| 3eem | 53V | Uncharacterized protein | / | 0.446 | |
| 3fy8 | XCF | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 3fyv | XCF | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 3ihg | VAK | Aklavinone 12-hydroxylase RdmE | / | 0.446 | |
| 3neg | PYV | Abscisic acid receptor PYL1 | / | 0.446 | |
| 3nxv | D2F | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.446 | |
| 4h98 | 14Q | Uncharacterized protein | / | 0.446 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.446 | |
| 1exa | 394 | Retinoic acid receptor gamma | / | 0.445 | |
| 1ie4 | T44 | Transthyretin | / | 0.445 | |
| 1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.445 | |
| 1y2e | 5DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.445 | |
| 2ibz | SMA | Cytochrome b | / | 0.445 | |
| 2y30 | SM8 | Putative repressor SimReg2 | / | 0.445 | |
| 2yiu | SMA | Cytochrome b | / | 0.445 | |
| 3uk6 | ADP | RuvB-like 2 | 3.6.4.12 | 0.445 | |
| 4elb | 34R | Dihydrofolate reductase | / | 0.445 | |
| 4jv4 | 1OR | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.445 | |
| 4rh1 | 0TT | Spore photoproduct lyase | / | 0.445 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.445 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.444 | |
| 1nde | MON | Estrogen receptor beta | / | 0.444 | |
| 1ohk | COP | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
| 2qk8 | MTX | Dihydrofolate reductase | / | 0.444 | |
| 2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.444 | |
| 3fl8 | RAR | Dihydrofolate reductase | / | 0.444 | |
| 3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 3tdk | UPG | UDP-glucose 6-dehydrogenase | 1.1.1.22 | 0.444 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.444 | |
| 1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.443 | |
| 1ne6 | SP1 | cAMP-dependent protein kinase type I-alpha regulatory subunit | / | 0.443 | |
| 1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 1xuo | LA1 | Integrin alpha-L | / | 0.443 | |
| 2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 2h44 | 7CA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.443 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
| 2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 3gb4 | D3M | DdmC | / | 0.443 | |
| 3huc | G97 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3hx3 | RET | Retinaldehyde-binding protein 1 | / | 0.443 | |
| 3hyw | DCQ | Sulfide-quinone reductase | / | 0.443 | |
| 3qly | 55V | Uncharacterized protein | / | 0.443 | |
| 3sh2 | 5DR | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
| 3vt6 | 5YI | Vitamin D3 receptor | / | 0.443 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.443 | |
| 4iv4 | 1GS | Estrogen receptor | / | 0.443 | |
| 4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.443 | |
| 4l8u | 9AZ | Serum albumin | / | 0.443 | |
| 5ab6 | CAA | Nonspecific lipid-transfer protein, putative | / | 0.443 | |
| 5d7q | 4I5 | NAD-dependent protein deacetylase sirtuin-2 | 3.5.1 | 0.443 | |
| 1e1n | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.442 | |
| 1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 1xng | DND | NH(3)-dependent NAD(+) synthetase | 6.3.1.5 | 0.442 | |
| 2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 2obx | INI | 6,7-dimethyl-8-ribityllumazine synthase 2 | 2.5.1.78 | 0.442 | |
| 2qd3 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
| 3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.442 | |
| 3ce3 | 1FN | Hepatocyte growth factor receptor | 2.7.10.1 | 0.442 | |
| 3d4b | DZD | NAD-dependent protein deacetylase | / | 0.442 | |
| 3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
| 3ua5 | 06X | Cytochrome P450 2B6 | 1.14.13 | 0.442 | |
| 4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.442 | |
| 4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 4g95 | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 4if5 | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.442 | |
| 4kla | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.442 | |
| 5bt4 | 2LO | Bromodomain-containing protein 4 | / | 0.442 | |
| 1fd0 | 254 | Retinoic acid receptor gamma | / | 0.441 | |
| 1syn | F89 | Thymidylate synthase | / | 0.441 | |
| 1xdk | REA | Retinoic acid receptor beta | / | 0.441 | |
| 2bkt | RPF | Renin | 3.4.23.15 | 0.441 | |
| 2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.441 | |
| 2uag | UMA | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.441 | |
| 3clb | TMQ | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.441 | |
| 3cx5 | SMA | Cytochrome b | / | 0.441 | |
| 3d3e | D3E | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
| 3dl9 | V2H | Vitamin D 25-hydroxylase | / | 0.441 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3gkj | HC3 | Niemann-Pick C1 protein | / | 0.441 | |
| 3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3s41 | S41 | Glucokinase | 2.7.1.2 | 0.441 | |
| 3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
| 3vru | YS3 | Vitamin D3 receptor | / | 0.441 | |
| 3zia | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.441 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.441 | |
| 4bub | ADP | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--LD-lysine ligase | / | 0.441 | |
| 4dm8 | REA | Retinoic acid receptor beta | / | 0.441 | |
| 4fhf | 0TT | Spore photoproduct lyase | / | 0.441 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.441 | |
| 1kyz | FER | Caffeic acid 3-O-methyltransferase | 2.1.1.68 | 0.440 | |
| 1ly3 | COG | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 1mcz | RMN | Benzoylformate decarboxylase | 4.1.1.7 | 0.440 | |
| 1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.440 | |
| 2a9z | 26A | Adenosine kinase | 2.7.1.20 | 0.440 | |
| 2fs4 | PZ1 | Renin | 3.4.23.15 | 0.440 | |
| 2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.440 | |
| 3d5w | ADP | Serine/threonine-protein kinase PLK | / | 0.440 | |
| 3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
| 3png | 8CX | Nitric oxide synthase, brain | 1.14.13.39 | 0.440 | |
| 3qlh | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
| 3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 4kfj | 1R0 | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 4v12 | POG | MaoC like domain protein | / | 0.440 |